Please login to the form below

Not currently logged in
Email:
Password:

trial failures

This page shows the latest trial failures news and features for those working in and with pharma, biotech and healthcare.

Realm toppled by second mid-stage trial flop

Realm toppled by second mid-stage trial flop

PR022 did not show the desired effect in this trial,” said Alex Martin, the biotech’s CEO. ... considerably after the twin trial failures.

Latest news

  • Reviews start for Pfizer’s wildcard lung cancer drug dacomitinib Reviews start for Pfizer’s wildcard lung cancer drug dacomitinib

    Regulatory reviews have started for Pfizer’s non-small cell lung cancer drug dacomitinib on both sides of the Atlantic, four years after a pair of trial failures left its future ... Dacomitinib missed its objectives in two phase III trials reported in

  • Pharma sales help Bayer escape the worst from a bumpy 2017 Pharma sales help Bayer escape the worst from a bumpy 2017

    easy”. For its pharmaceuticals business the ‘downs’ included several late-stage trial failures towards the end of the year. ... Among them were a 7, 000 patient study of Xarelto in secondary stroke, a combination trial of Eylea and a drug-device

  • Merck BACE inhibitor adds to litany of Alzheimer's trial failures Merck BACE inhibitor adds to litany of Alzheimer's trial failures

    The EPOCH trial enrolled patients with established mild-to-moderate Alzheimer symptoms and was due to generate primary results later this year and complete fully in 2019. ... verubecestat. Merck (known as MSD outside the US and Canada) is currently

  • Choose or lose Choose or lose

    In essence, it involves sifting through thousands of 'industry episodes' such as launches, trial results, acquisitions and failures. ... The latest trial results from Amgen point out how its model is trying to create clear space from statins.

  • Tau protein drug fails late-stage trial Tau protein drug fails late-stage trial

    Much of the pharma industry's efforts in Alzheimer's have been directed at the amyloid plaques seen in the brains of patients – resulting in a string of trial failures. ... This approach has earlier failures too, however, with casualties including

More from news
Approximately 5 fully matching, plus 25 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics